<DOC>
	<DOCNO>NCT00935389</DOCNO>
	<brief_summary>The purpose study analyze clinical effect adverse reaction tripterygium glycoside ( TW ) CTX LN-V patient gross proteinuria .</brief_summary>
	<brief_title>Prospective Study TW Treatment LN Type V With Gross Proteinuria</brief_title>
	<detailed_description>Compared cyclophosphamide ( CTX ) , analyze clinical effect adverse reaction tripterygium glycoside ( TW ) LN-V patient gross proteinuria .</detailed_description>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<criteria>1 . SLE patient age 1860 year , comply ISN/RPS classification . 2 . Urine proteinâ‰¥3.0g/24h , Alb &lt; 30g/L Scr &lt; 1.5mg/dL . 3 . All case type IV , confirm renal biopsy . 4 . All patient sign informed consent willing followup time 1 . Accepted drug therapy , CTX MMF CsA FK506 TW 2 week late 3 month . 2 . Scr level 1.5mg/dL , last 3 month . 3 . Heart , lung central nervous system involve combine severe infection . 4 . With liver function abnormal , ALT AST two time normal . 5 . Pregnant woman patient still lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>